A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
Clinical trial NCT03298906 · COMPLETED
Trial details
- NCT number
- NCT03298906
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2017-11-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.